Cancer seems to be less of an issue with biologic DMARDs and with NSAIDs there are bigger cardiovascular issues to be worried about. But either way it’s trading bad outcomes.
My observation of online communities for chronic diseases is that there are some people that read new research papers and share new findings because there’s so little else they can do. Knowledge in those communities spreads fast (but so does bullshit unfortunately).
Cancer seems to be less of an issue with biologic DMARDs and with NSAIDs there are bigger cardiovascular issues to be worried about. But either way it’s trading bad outcomes.
My observation of online communities for chronic diseases is that there are some people that read new research papers and share new findings because there’s so little else they can do. Knowledge in those communities spreads fast (but so does bullshit unfortunately).